Early research (Phase 1)Study completedNCT06224543What this trial is testingMR Image Synthesis With Low Gadobutrol Dose and AIWho this might be right forEnhancing Brain Lesions Subtle Medical 60
Not applicableStudy completedNCT00214175What this trial is testingDetermination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance RadiotherapyWho this might be right forGliomaBrain Neoplasms University of Wisconsin, Madison 44
Large-scale testing (Phase 3)Looking for participantsNCT07275814What this trial is testingA Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) LesionsWho this might be right forFor Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions Shanghai Shengdi Pharmaceutical Co., Ltd 250
Not applicableStudy completedNCT01312363What this trial is testingStudy for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) PatientsWho this might be right forAlzheimer's Disease Seoul National University Hospital 300
Not applicableStudy completedNCT07128212What this trial is testingAtorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1Who this might be right forIschemic White Matter Lesions (WMIL)Cerebral Small Vessel DiseaseVascular Cell Adhesion Molecule-1+1 more Suzhou Municipal Hospital of Anhui Province 401
Not applicableStudy completedNCT02506244What this trial is testingMHealth Screening to Prevent StrokesWho this might be right forAtrial Fibrillation Scripps Translational Science Institute 6,135
Not applicableStudy completedNCT02250755What this trial is testingMRI Perfusion on T1 and T2 Brain Lesion(s)Who this might be right forLung Carcinoma Metastatic to the Brain University Hospital, Lille 30
Early research (Phase 1)Study completedNCT02728947What this trial is testingPharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's DiseaseWho this might be right forParkinson's Disease Luye Pharma Group Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT00879658What this trial is testingSafety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple SclerosisWho this might be right forRelapsing-remitting Multiple Sclerosis Novartis Pharmaceuticals 297
Testing effectiveness (Phase 2)Study completedNCT00013585What this trial is testingSafety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV PatientsWho this might be right forCognition DisordersHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 127
Testing effectiveness (Phase 2)Study completedNCT00676715What this trial is testingThe Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-Remitting Genentech, Inc. 220
Testing effectiveness (Phase 2)Study completedNCT01024907What this trial is testingProton Beam Radiation Therapy in Treating Patients With Low Grade GliomasWho this might be right forAdult Brain TumorAdult Brain Stem GliomaAdult Diffuse Astrocytoma+9 more Abramson Cancer Center at Penn Medicine 23
Not applicableStudy completedNCT04178395What this trial is testingEarly Neurophysiological Interventions in Acute Cerebral LesionsWho this might be right forStrokeAcute Stroke Sara Yagüe MD 20
Testing effectiveness (Phase 2)Study completedNCT02720445What this trial is testingMemory Improvement Through Nicotine Dosing (MIND) StudyWho this might be right forMild Cognitive Impairment University of Southern California 348
Not applicableStudy completedNCT05985031What this trial is testingReciprocal Inhibition Versus Reciprocal Facilitation In Spinal Cord Injury PatientsWho this might be right forSpinal Cord Injuries Istanbul Physical Medicine Rehabilitation Training and Research Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05359653What this trial is testingAssessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyWho this might be right forMultiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more University of California, San Francisco 74
Not applicableStudy completedNCT02122276What this trial is testingEffects of Continuous Passive Motion on the Spinal Circuitries and Its Adaptation in Patients With Spasticity Resulting From Upper Motor Neuron LesionsWho this might be right forSpinal Cord Injury(SCI) Chang Gung University 7
Testing effectiveness (Phase 2)Study completedNCT01418820What this trial is testingParaorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic LesionsWho this might be right forComplete HemianopiaIncomplete HemianopiaScotoma+4 more University of Magdeburg 32
Large-scale testing (Phase 3)Study completedNCT00799890What this trial is testingSunphenon in Progressive Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis Friedemann Paul 61
Not applicableUnknownNCT04488965What this trial is testingStudy of the Therapeutic Effects of Cortical Autograft Implantation in Patients With Cerebral IschemiaWho this might be right forIschemic Stroke Centre Hospitalier Universitaire Vaudois 10